|
IMPACT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.97119995273931E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87240001281452E-10 |
| Normal-vs-Stage2 |
2.27919999984394E-07 |
| Normal-vs-Stage3 |
2.024500E-04 |
| Normal-vs-Stage4 |
2.15260000047124E-07 |
| Stage1-vs-Stage2 |
9.556400E-01 |
| Stage1-vs-Stage3 |
7.937000E-01 |
| Stage1-vs-Stage4 |
2.151400E-01 |
| Stage2-vs-Stage3 |
7.945600E-01 |
| Stage2-vs-Stage4 |
3.208200E-01 |
| Stage3-vs-Stage4 |
2.699800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.89930002018002E-10 |
| Normal-vs-AfricanAmerican |
2.68990052454399E-10 |
| Normal-vs-Asian |
3.12530000001754E-06 |
| Caucasian-vs-AfricanAmerican |
2.973600E-01 |
| Caucasian-vs-Asian |
2.351400E-01 |
| AfricanAmerican-vs-Asian |
2.216800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.92660390050537E-11 |
| Normal-vs-Female |
5.66239999999496E-07 |
| Male-vs-Female |
1.609640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.1716000027422E-08 |
| Normal-vs-Extreme_Weight |
1.43259959450859E-10 |
| Normal-vs-Obese |
3.72010000004863E-06 |
| Normal-vs-Extreme_Obese |
4.19500000004014E-06 |
| Normal_Weight-vs-Extreme_Weight |
6.832400E-01 |
| Normal_Weight-vs-Obese |
4.706600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.474600E-01 |
| Extreme_Weight-vs-Obese |
2.514800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.381800E-01 |
| Obese-vs-Extreme_Obese |
4.149200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.46109998836408E-09 |
| Normal-vs-Age(41-60Yrs) |
1.94479999882091E-08 |
| Normal-vs-Age(61-80Yrs) |
1.26750054896263E-10 |
| Normal-vs-Age(81-100Yrs) |
9.86130000000252E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.155600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.445790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.560030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.436200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.682400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.288400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.35810038162754E-10 |
| Normal-VS-Type2 PRCC |
8.90280000054311E-07 |
| Normal-VS-KIRP CIMP |
1.0060000055212E-08 |
| Normal-VS-Unclassified PRCC |
1.351260E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.816200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.329600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.488200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.059530E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.911800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.519900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.19549966884847E-11 |
| Normal-vs-N1 |
1.02520000266892E-08 |
| Normal-vs-N2 |
3.74990039020417E-10 |
| N0-vs-N1 |
8.168200E-01 |
| N0-vs-N2 |
8.340000E-03 |
| N1-vs-N2 |
1.048270E-02 |
|
|
